-
1
-
-
67650874081
-
Cancer statistics 2009
-
Jemal, A., R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun. 2009. Cancer statistics, 2009. CA Cancer J Clin 59:225-249.
-
(2009)
CA Cancer J Clin
, vol.59
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
2
-
-
33745541234
-
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
-
Weisenberger, D.J., K.D. Siegmund, M. Campan, J. Young, T.I. Long, M.A. Faasse, G.H. Kang, M. Widschwendter, D. Weener, D. Buchanan, H. Koh, L. Simms, M. Barker, B. Leggett, J. Levine, M. Kim, A.J. French, S.N. Thibodeau, J. Jass, R. Haile, and P.W. Laird. 2006. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38:787-793.
-
(2006)
Nat Genet
, vol.38
, pp. 787-793
-
-
Weisenberger, D.J.1
Siegmund, K.D.2
Campan, M.3
Young, J.4
Long, T.I.5
Faasse, M.A.6
Kang, G.H.7
Widschwendter, M.8
Weener, D.9
Buchanan, D.10
Koh, H.11
Simms, L.12
Barker, M.13
Leggett, B.14
Levine, J.15
Kim, M.16
French, A.J.17
Thibodeau, S.N.18
Jass, J.19
Haile, R.20
Laird, P.W.21
more..
-
3
-
-
33846576622
-
Epigenetic stem cell signature in cancer
-
Widschwendter, M., H. Fiegl, D. Egle, E. Mueller-Holzner, G. Spizzo, C. Marth, D.J. Weisenberger, M. Campan, J. Young, I. Jacobs, and P.W. Laird. 2007. Epigenetic stem cell signature in cancer. Nat Genet 39:157-158.
-
(2007)
Nat Genet
, vol.39
, pp. 157-158
-
-
Widschwendter, M.1
Fiegl, H.2
Egle, D.3
Mueller-Holzner, E.4
Spizzo, G.5
Marth, C.6
Weisenberger, D.J.7
Campan, M.8
Young, J.9
Jacobs, I.10
Laird, P.W.11
-
4
-
-
0347444723
-
MicroRNAs: genomics, biogenesis, mechanism, and function
-
Bartel, D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
-
(2004)
Cell
, vol.116
, pp. 281-297
-
-
Bartel, D.P.1
-
5
-
-
33747876113
-
MicroRNA-cancer connection: the beginning of a new tale
-
Calin GA, C.C. 2006. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66:7390-7394.
-
(2006)
Cancer Res
, vol.66
, pp. 7390-7394
-
-
Calin, G.A.C.C.1
-
6
-
-
0033616620
-
Regulation of p53 expression by thymidylate synthase
-
Ju, J., J. Pedersen-Lane, F. Maley, and E. Chu. 1999. Regulation of p53 expression by thymidylate synthase. Proc Natl Acad Sci U S A 96:3769-3774.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 3769-3774
-
-
Ju, J.1
Pedersen-Lane, J.2
Maley, F.3
Chu, E.4
-
7
-
-
0029766553
-
Translational regulation of human p53 gene expression
-
Fu, L., M.D. Minden, and S. Benchimol. 1996. Translational regulation of human p53 gene expression. Embo J 15:4392-4401.
-
(1996)
Embo J
, vol.15
, pp. 4392-4401
-
-
Fu, L.1
Minden, M.D.2
Benchimol, S.3
-
8
-
-
18744396337
-
Frequent deletions and downregulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
-
Calin, G.A., C.D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, E. Noch, H. Aldler, S. Rattan, M. Keating, K. Rai, L. Rassenti, T. Kipps, M. Negrini, F. Bullrich, and C.M. Croce. 2002. Frequent deletions and downregulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99:15524-15529.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 15524-15529
-
-
Calin, G.A.1
Dumitru, C.D.2
Shimizu, M.3
Bichi, R.4
Zupo, S.5
Noch, E.6
Aldler, H.7
Rattan, S.8
Keating, M.9
Rai, K.10
Rassenti, L.11
Kipps, T.12
Negrini, M.13
Bullrich, F.14
Croce, C.M.15
-
9
-
-
0027751663
-
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
-
Lee, R.C., R.L. Feinbaum, and V. Ambros. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854.
-
(1993)
Cell
, vol.75
, pp. 843-854
-
-
Lee, R.C.1
Feinbaum, R.L.2
Ambros, V.3
-
10
-
-
33644853907
-
The colorectal microRNAome
-
Cummins, J.M., Y. He, R.J. Leary, R. Pagliarini, L.A. Diaz, Jr., T. Sjoblom, O. Barad, Z. Bentwich, A.E. Szafranska, E. Labourier, C.K. Raymond, B.S. Roberts, H. Juhl, K.W. Kinzler, B. Vogelstein, and V.E. Velculescu. 2006. The colorectal microRNAome. Proc Natl Acad Sci U S A 103:3687-3692.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 3687-3692
-
-
Cummins, J.M.1
He, Y.2
Leary, R.J.3
Pagliarini, R.4
Diaz Jr., L.A.5
Sjoblom, T.6
Barad, O.7
Bentwich, Z.8
Szafranska, A.E.9
Labourier, E.10
Raymond, C.K.11
Roberts, B.S.12
Juhl, H.13
Kinzler, K.W.14
Vogelstein, B.15
Velculescu, V.E.16
-
11
-
-
24644480213
-
Inhibition of translational initiation by Let-7 MicroRNA in human cells
-
Pillai, R.S., S.N. Bhattacharyya, C.G. Artus, T. Zoller, N. Cougot, E. Basyuk, E. Bertrand, and W. Filipowicz. 2005. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309:1573-1576.
-
(2005)
Science
, vol.309
, pp. 1573-1576
-
-
Pillai, R.S.1
Bhattacharyya, S.N.2
Artus, C.G.3
Zoller, T.4
Cougot, N.5
Basyuk, E.6
Bertrand, E.7
Filipowicz, W.8
-
12
-
-
30344456432
-
Clarifications on miRNA and cancer
-
Ruvkun, G. 2006. Clarifications on miRNA and cancer. Science 311:36-37.
-
(2006)
Science
, vol.311
, pp. 36-37
-
-
Ruvkun, G.1
-
13
-
-
0022382513
-
Posttranscriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9
-
Dony, C., M. Kessel, and P. Gruss. 1985. Posttranscriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9. Nature 317:636-639.
-
(1985)
Nature
, vol.317
, pp. 636-639
-
-
Dony, C.1
Kessel, M.2
Gruss, P.3
-
14
-
-
71049136170
-
MicroRNAs in colorectal cancer: translation of molecular biology into clinical application
-
Slaby, O., M. Svoboda, J. Michalek, and R. Vyzula. 2009. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 8:102.
-
(2009)
Mol Cancer
, vol.8
, pp. 102
-
-
Slaby, O.1
Svoboda, M.2
Michalek, J.3
Vyzula, R.4
-
15
-
-
0142120587
-
Reduced accumulation of specific microRNAs in colorectal neoplasia
-
Michael, M.Z., O.C. SM, N.G. van Holst Pellekaan, G.P. Young, and R.J. James. 2003. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1:882-891.
-
(2003)
Mol Cancer Res
, vol.1
, pp. 882-891
-
-
Michael, M.Z.1
O'Connor, S.M.2
van Holst Pellekaan, N.G.3
Young, G.P.4
James, R.J.5
-
16
-
-
33646258751
-
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer
-
Xi, Y., R. Shalgi, O. Fodstad, Y. Pilpel, and J. Ju. 2006. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 12:2014-2024.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 2014-2024
-
-
Xi, Y.1
Shalgi, R.2
Fodstad, O.3
Pilpel, Y.4
Ju, J.5
-
17
-
-
58149340662
-
miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit
-
Song, B., Y. Wang, K. Kudo, E.J. Gavin, Y. Xi, and J. Ju. 2008. miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res 14:8080-8086.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 8080-8086
-
-
Song, B.1
Wang, Y.2
Kudo, K.3
Gavin, E.J.4
Xi, Y.5
Ju, J.6
-
18
-
-
70450237022
-
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
-
Song, B., Y. Wang, Y. Xi, K. Kudo, S. Bruheim, G.I. Botchkina, E. Gavin, Y. Wan, A. Formentini, M. Kornmann, O. Fodstad, and J. Ju. 2009. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 28:4065-4074.
-
(2009)
Oncogene
, vol.28
, pp. 4065-4074
-
-
Song, B.1
Wang, Y.2
Xi, Y.3
Kudo, K.4
Bruheim, S.5
Botchkina, G.I.6
Gavin, E.7
Wan, Y.8
Formentini, A.9
Kornmann, M.10
Fodstad, O.11
Ju, J.12
-
19
-
-
33750726715
-
Non-coding MicroRNAs hsa-let-7g and hsamiR-181b are Associated with Chemoresponse to S-1 in Colon Cancer
-
Nakajima, G., K. Hayashi, Y. Xi, K. Kudo, K. Uchida, K. Takasaki, M. Yamamoto, and J. Ju. 2006. Non-coding MicroRNAs hsa-let-7g and hsamiR-181b are Associated with Chemoresponse to S-1 in Colon Cancer. Cancer Genomics Proteomics 3:317-324.
-
(2006)
Cancer Genomics Proteomics
, vol.3
, pp. 317-324
-
-
Nakajima, G.1
Hayashi, K.2
Xi, Y.3
Kudo, K.4
Uchida, K.5
Takasaki, K.6
Yamamoto, M.7
Ju, J.8
-
20
-
-
85128713958
-
Prognostic Values of microRNAs in Colorectal Cancer
-
Xi, Y., A. Formentini, M. Chien, D.B. Weir, J.J. Russo, J. Ju, and M. Kornmann. 2006. Prognostic Values of microRNAs in Colorectal Cancer. Biomark Insights 2:113-121.
-
(2006)
Biomark Insights
, vol.2
, pp. 113-121
-
-
Xi, Y.1
Formentini, A.2
Chien, M.3
Weir, D.B.4
Russo, J.J.5
Ju, J.6
Kornmann, M.7
-
21
-
-
0034048729
-
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase
-
Salonga, D., K.D. Danenberg, M. Johnson, R. Metzger, S. Groshen, D.D. Tsao-Wei, H.J. Lenz, C.G. Leichman, L. Leichman, R.B. Diasio, and P.V. Danenberg. 2000. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 6:1322-1327.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 1322-1327
-
-
Salonga, D.1
Danenberg, K.D.2
Johnson, M.3
Metzger, R.4
Groshen, S.5
Tsao-Wei, D.D.6
Lenz, H.J.7
Leichman, C.G.8
Leichman, L.9
Diasio, R.B.10
Danenberg, P.V.11
-
22
-
-
47949110995
-
Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil Is it time to move forward?
-
Showalter, S.L., T.N. Showalter, A. Witkiewicz, R. Havens, E.P. Kennedy, T. Hucl, S.E. Kern, C.J. Yeo, and J.R. Brody. 2008. Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil. Is it time to move forward? Cancer Biol Ther 7:986-994.
-
(2008)
Cancer Biol Ther
, vol.7
, pp. 986-994
-
-
Showalter, S.L.1
Showalter, T.N.2
Witkiewicz, A.3
Havens, R.4
Kennedy, E.P.5
Hucl, T.6
Kern, S.E.7
Yeo, C.J.8
Brody, J.R.9
-
23
-
-
29844453626
-
Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase
-
Smorenburg, C.H., G.J. Peters, C.J. van Groeningen, P. Noordhuis, K. Smid, A.M. van Riel, W. Dercksen, H.M. Pinedo, and G. Giaccone. 2006. Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase. Ann Oncol 17:35-42.
-
(2006)
Ann Oncol
, vol.17
, pp. 35-42
-
-
Smorenburg, C.H.1
Peters, G.J.2
van Groeningen, C.J.3
Noordhuis, P.4
Smid, K.5
van Riel, A.M.6
Dercksen, W.7
Pinedo, H.M.8
Giaccone, G.9
-
24
-
-
0025894713
-
p53 mutations in human cancers
-
Hollstein, M., D. Sidransky, B. Vogelstein, and C.C. Harris. 1991. p53 mutations in human cancers. Science 253:49-53.
-
(1991)
Science
, vol.253
, pp. 49-53
-
-
Hollstein, M.1
Sidransky, D.2
Vogelstein, B.3
Harris, C.C.4
-
25
-
-
34250851115
-
A microRNA component of the p53 tumour suppressor network
-
He, L., X. He, L.P. Lim, E. de Stanchina, Z. Xuan, Y. Liang, W. Xue, L. Zender, J. Magnus, D. Ridzon, A.L. Jackson, P.S. Linsley, C. Chen, S.W. Lowe, M.A. Cleary, and G.J. Hannon. 2007. A microRNA component of the p53 tumour suppressor network. Nature 447:1130-1134.
-
(2007)
Nature
, vol.447
, pp. 1130-1134
-
-
He, L.1
He, X.2
Lim, L.P.3
de Stanchina, E.4
Xuan, Z.5
Liang, Y.6
Xue, W.7
Zender, L.8
Magnus, J.9
Ridzon, D.10
Jackson, A.L.11
Linsley, P.S.12
Chen, C.13
Lowe, S.W.14
Cleary, M.A.15
Hannon, G.J.16
-
26
-
-
34249817549
-
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
-
Chang, T.C., E.A. Wentzel, O.A. Kent, K. Ramachandran, M. Mullendore, K.H. Lee, G. Feldmann, M. Yamakuchi, M. Ferlito, C.J. Lowenstein, D.E. Arking, M.A. Beer, A. Maitra, and J.T. Mendell. 2007. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26:745-752.
-
(2007)
Mol Cell
, vol.26
, pp. 745-752
-
-
Chang, T.C.1
Wentzel, E.A.2
Kent, O.A.3
Ramachandran, K.4
Mullendore, M.5
Lee, K.H.6
Feldmann, G.7
Yamakuchi, M.8
Ferlito, M.9
Lowenstein, C.J.10
Arking, D.E.11
Beer, M.A.12
Maitra, A.13
Mendell, J.T.14
-
27
-
-
34249822779
-
Transcriptional activation of miR-34a contributes to p53-mediated apoptosis
-
Raver-Shapira N, M.E., Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. 2007. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26:731-743.
-
(2007)
Mol Cell
, vol.26
, pp. 731-743
-
-
Raver-Shapira, N.M.E.1
Meiri, E.2
Spector, Y.3
Rosenfeld, N.4
Moskovits, N.5
Bentwich, Z.6
Oren, M.7
-
28
-
-
57749116172
-
Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
-
Sara A. Georges, M.C.B., Soo-yeon Kim, Janell M. Schelter, Jane Guo, Aaron N. Chang, Aimee L. Jackson, Michael O. Carleton, Peter S. Linsley, Michele A. Cleary, and B. Nelson Chau. 2008. Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Cancer Res 68:10105-10112.
-
(2008)
Cancer Res
, vol.68
, pp. 10105-10112
-
-
Georges, S.A.1
Biery, M.C.2
Kim, S.-Y.3
Schelter, J.M.4
Guo, J.5
Chang, A.N.6
Jackson, A.L.7
Carleton, M.O.8
Linsley, P.S.9
Cleary, M.A.10
Nelson Chau, B.11
-
29
-
-
57749099102
-
p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest
-
Christian J. Braun, X.Z., Irina Savelyeva, Sonja Wolff, Ute M. Moll, Troels Schepeler, Torben F. Ørntoft, Claus L. Andersen, and Matthias Dobbelstein. 2008. p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest. Cancer Res 68:10094-10104.
-
(2008)
Cancer Res
, vol.68
, pp. 10094-10104
-
-
Christian, J.1
Braun, X.Z.2
Irina, S.3
Sonja, W.4
Ute, M.M.5
Troels, S.6
Torben, F.Ø.7
Claus, L.A.8
Matthias, D.9
-
30
-
-
77951597361
-
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
-
Song, B., Wang, T., Titmus, M., Botchkina, G., Formentini, A., Kornmann, M., J Ju. 2010. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells Mol Cancer 9:96.
-
(2010)
Mol Cancer
, vol.9
, pp. 96
-
-
Song, B.1
Wang, T.2
Titmus, M.3
Botchkina, G.4
Formentini, A.5
Kornmann, M.6
Ju, J.7
-
31
-
-
34548059198
-
A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance
-
Mishra PJ, H.R., Mishra PJ, Longo-Sorbello GS, Banerjee D, and Bertino JR. 2007. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci U S A 104:13513-13518.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 13513-13518
-
-
Mishra, P.J.H.R.1
Mishra, P.J.2
Longo-Sorbello, G.S.3
Banerjee, D.4
Bertino, J.R.5
-
32
-
-
77949495697
-
MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism
-
Mishra, P.J., B. Song, Y. Wang, R. Humeniuk, D. Banerjee, G. Merlino, J. Ju, and J.R. Bertino. 2009. MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism. PLoS One 4:e8445.
-
(2009)
PLoS One
, vol.4
-
-
Mishra, P.J.1
Song, B.2
Wang, Y.3
Humeniuk, R.4
Banerjee, D.5
Merlino, G.6
Ju, J.7
Bertino, J.R.8
-
33
-
-
69949098536
-
miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements
-
Lal, A., F. Navarro, C.A. Maher, L.E. Maliszewski, N. Yan, E. O'Day, D. Chowdhury, D.M. Dykxhoorn, P. Tsai, O. Hofmann, K.G. Becker, M. Gorospe, W. Hide, and J. Lieberman. 2009. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol Cell 35:610-625.
-
(2009)
Mol Cell
, vol.35
, pp. 610-625
-
-
Lal, A.1
Navarro, F.2
Maher, C.A.3
Maliszewski, L.E.4
Yan, N.5
O'Day, E.6
Chowdhury, D.7
Dykxhoorn, D.M.8
Tsai, P.9
Hofmann, O.10
Becker, K.G.11
Gorospe, M.12
Hide, W.13
Lieberman, J.14
-
34
-
-
70349871321
-
MicroRNA expression, survival, and response to interferon in liver cancer
-
Ji, J., J. Shi, A. Budhu, Z. Yu, M. Forgues, S. Roessler, S. Ambs, Y. Chen, P.S. Meltzer, C.M. Croce, L.X. Qin, K. Man, C.M. Lo, J. Lee, I.O. Ng, J. Fan, Z.Y. Tang, H.C. Sun, and X.W. Wang. 2009. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361:1437-1447.
-
(2009)
N Engl J Med
, vol.361
, pp. 1437-1447
-
-
Ji, J.1
Shi, J.2
Budhu, A.3
Yu, Z.4
Forgues, M.5
Roessler, S.6
Ambs, S.7
Chen, Y.8
Meltzer, P.S.9
Croce, C.M.10
Qin, L.X.11
Man, K.12
Lo, C.M.13
Lee, J.14
Ng, I.O.15
Fan, J.16
Tang, Z.Y.17
Sun, H.C.18
Wang, X.W.19
-
35
-
-
66449136951
-
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model
-
Kota, J., R.R. Chivukula, K.A. O'Donnell, E.A. Wentzel, C.L. Montgomery, H.W. Hwang, T.C. Chang, P. Vivekanandan, M. Torbenson, K.R. Clark, J.R. Mendell, and J.T. Mendell. 2009. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137:1005-1017.
-
(2009)
Cell
, vol.137
, pp. 1005-1017
-
-
Kota, J.1
Chivukula, R.R.2
O'Donnell, K.A.3
Wentzel, E.A.4
Montgomery, C.L.5
Hwang, H.W.6
Chang, T.C.7
Vivekanandan, P.8
Torbenson, M.9
Clark, K.R.10
Mendell, J.R.11
Mendell, J.T.12
-
36
-
-
33751227501
-
DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint
-
Sansam, C.L., J.L. Shepard, K. Lai, A. Ianari, P.S. Danielian, A. Amsterdam, N. Hopkins, and J.A. Lees. 2006. DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint. Genes Dev 20:3117-3129.
-
(2006)
Genes Dev
, vol.20
, pp. 3117-3129
-
-
Sansam, C.L.1
Shepard, J.L.2
Lai, K.3
Ianari, A.4
Danielian, P.S.5
Amsterdam, A.6
Hopkins, N.7
Lees, J.A.8
-
37
-
-
70450237022
-
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
-
Song, B., Y. Wang, Y. Xi, K. Kudo, S. Bruheim, G.I. Botchkina, E. Gavin, Y. Wan, A. Formentini, M. Kornmann, O. Fodstad, and J. Ju. 2009. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene. 28: 4065-4074.
-
(2009)
Oncogene
, vol.28
, pp. 4065-4074
-
-
Song, B.1
Wang, Y.2
Xi, Y.3
Kudo, K.4
Bruheim, S.5
Botchkina, G.I.6
Gavin, E.7
Wan, Y.8
Formentini, A.9
Kornmann, M.10
Fodstad, O.11
Ju, J.12
-
38
-
-
34748837455
-
Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples
-
Xi, Y., G. Nakajima, E. Gavin, C.G. Morris, K. Kudo, K. Hayashi, and J. Ju. 2007. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. Rna 13:1668-1674.
-
(2007)
Rna
, vol.13
, pp. 1668-1674
-
-
Xi, Y.1
Nakajima, G.2
Gavin, E.3
Morris, C.G.4
Kudo, K.5
Hayashi, K.6
Ju, J.7
-
39
-
-
48749122914
-
Circulating microRNAs as stable blood-based markers for cancer detection
-
Mitchell, P.S., R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O'Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B. Martin, and M. Tewari. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105:10513-10518.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 10513-10518
-
-
Mitchell, P.S.1
Parkin, R.K.2
Kroh, E.M.3
Fritz, B.R.4
Wyman, S.K.5
Pogosova-Agadjanyan, E.L.6
Peterson, A.7
Noteboom, J.8
O'Briant, K.C.9
Allen, A.10
Lin, D.W.11
Urban, N.12
Drescher, C.W.13
Knudsen, B.S.14
Stirewalt, D.L.15
Gentleman, R.16
Vessella, R.L.17
Nelson, P.S.18
Martin, D.B.19
Tewari, M.20
more..
-
40
-
-
77953192081
-
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
-
Huang, Z., D. Huang, S. Ni, Z. Peng, W. Sheng, and X. Du. 2009. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 27(1): 118-126
-
(2009)
Int J Cancer
, vol.27
, Issue.1
, pp. 118-126
-
-
Huang, Z.1
Huang, D.2
Ni, S.3
Peng, Z.4
Sheng, W.5
Du, X.6
-
41
-
-
66049112674
-
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
-
Ng, E.K., W.W. Chong, H. Jin, E.K. Lam, V.Y. Shin, J. Yu, T.C. Poon, S.S. Ng, and J.J. Sung. 2009. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58:1375-1381.
-
(2009)
Gut
, vol.58
, pp. 1375-1381
-
-
Ng, E.K.1
Chong, W.W.2
Jin, H.3
Lam, E.K.4
Shin, V.Y.5
Yu, J.6
Poon, T.C.7
Ng, S.S.8
Sung, J.J.9
-
42
-
-
51049119231
-
Diagnostic and prognostic microRNAs in stage II colon cancer
-
Schepeler, T., J.T. Reinert, M.S. Ostenfeld, L.L. Christensen, A.N. Silahtaroglu, L. Dyrskjot, C. Wiuf, F.J. Sorensen, M. Kruhoffer, S. Laurberg, S. Kauppinen, T.F. Orntoft, and C.L. Andersen. 2008. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68:6416-6424.
-
(2008)
Cancer Res
, vol.68
, pp. 6416-6424
-
-
Schepeler, T.1
Reinert, J.T.2
Ostenfeld, M.S.3
Christensen, L.L.4
Silahtaroglu, A.N.5
Dyrskjot, L.6
Wiuf, C.7
Sorensen, F.J.8
Kruhoffer, M.9
Laurberg, S.10
Kauppinen, S.11
Orntoft, T.F.12
Andersen, C.L.13
-
43
-
-
65349162096
-
Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression
-
Peter, M.E. 2009. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8:843-852.
-
(2009)
Cell Cycle
, vol.8
, pp. 843-852
-
-
Peter, M.E.1
-
44
-
-
43049103824
-
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
-
Gregory, P.A., A.G. Bert, E.L. Paterson, S.C. Barry, A. Tsykin, G. Farshid, M.A. Vadas, Y. Khew-Goodall, and G.J. Goodall. 2008. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10:593-601.
-
(2008)
Nat Cell Biol
, vol.10
, pp. 593-601
-
-
Gregory, P.A.1
Bert, A.G.2
Paterson, E.L.3
Barry, S.C.4
Tsykin, A.5
Farshid, G.6
Vadas, M.A.7
Khew-Goodall, Y.8
Goodall, G.J.9
-
45
-
-
38749089854
-
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma
-
Schetter, A.J., S.Y. Leung, J.J. Sohn, K.A. Zanetti, E.D. Bowman, N. Yanaihara, S.T. Yuen, T.L. Chan, D.L. Kwong, G.K. Au, C.G. Liu, G.A. Calin, C.M. Croce, and C.C. Harris. 2008. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299:425-436.
-
(2008)
JAMA
, vol.299
, pp. 425-436
-
-
Schetter, A.J.1
Leung, S.Y.2
Sohn, J.J.3
Zanetti, K.A.4
Bowman, E.D.5
Yanaihara, N.6
Yuen, S.T.7
Chan, T.L.8
Kwong, D.L.9
Au, G.K.10
Liu, C.G.11
Calin, G.A.12
Croce, C.M.13
Harris, C.C.14
-
46
-
-
39049128249
-
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer
-
Slaby, O., M. Svoboda, P. Fabian, T. Smerdova, D. Knoflickova, M. Bednarikova, R. Nenutil, and R. Vyzula. 2007. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72:397-402.
-
(2007)
Oncology
, vol.72
, pp. 397-402
-
-
Slaby, O.1
Svoboda, M.2
Fabian, P.3
Smerdova, T.4
Knoflickova, D.5
Bednarikova, M.6
Nenutil, R.7
Vyzula, R.8
|